Cancer Cachexia: ASCO Guideline Rapid Recommendation Update
- PMID: 37467399
- DOI: 10.1200/JCO.23.01280
Cancer Cachexia: ASCO Guideline Rapid Recommendation Update
Abstract
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. See the Appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).
Similar articles
-
Management of Metastatic Renal Clear Cell Cancer: ASCO Guideline Rapid Recommendation Update.J Clin Oncol. 2023 Nov 20;41(33):5184-5186. doi: 10.1200/JCO.23.01977. Epub 2023 Oct 9. J Clin Oncol. 2023. PMID: 37812756
-
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.J Clin Oncol. 2023 Sep 20;41(27):4430-4432. doi: 10.1200/JCO.23.01261. Epub 2023 Jul 20. J Clin Oncol. 2023. PMID: 37471673
-
Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.J Clin Oncol. 2024 Sep 1;42(25):3058-3060. doi: 10.1200/JCO-24-01324. Epub 2024 Jul 23. J Clin Oncol. 2024. PMID: 39042842
-
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.J Clin Oncol. 2024 Jun 20;42(18):2233-2235. doi: 10.1200/JCO.24.00886. Epub 2024 May 20. J Clin Oncol. 2024. PMID: 38768407 Review.
-
Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update.J Clin Oncol. 2021 Oct 1;39(28):3182-3184. doi: 10.1200/JCO.21.01831. Epub 2021 Aug 18. J Clin Oncol. 2021. PMID: 34406872 Review.
Cited by
-
On the cusp of targeted therapy for cancer cachexia - what clinical benefits might we promise our patients?Nat Rev Clin Oncol. 2024 Nov 5. doi: 10.1038/s41571-024-00964-1. Online ahead of print. Nat Rev Clin Oncol. 2024. PMID: 39501040 No abstract available.
-
Appetite Loss in Patients with Advanced Cancer Treated at an Acute Palliative Care Unit.Curr Oncol. 2024 Oct 10;31(10):6061-6072. doi: 10.3390/curroncol31100452. Curr Oncol. 2024. PMID: 39451756 Free PMC article.
-
[Improving the nutritional situation of patients with advanced non-small cell lung cancer (NSCLC) through off-label medication].Strahlenther Onkol. 2024 Nov;200(11):997-999. doi: 10.1007/s00066-024-02299-3. Epub 2024 Sep 5. Strahlenther Onkol. 2024. PMID: 39235472 German. No abstract available.
-
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.Front Oncol. 2024 Jul 23;14:1362244. doi: 10.3389/fonc.2024.1362244. eCollection 2024. Front Oncol. 2024. PMID: 39109281 Free PMC article.
-
Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.Thorac Cancer. 2024 Sep;15(25):1831-1841. doi: 10.1111/1759-7714.15403. Epub 2024 Jul 29. Thorac Cancer. 2024. PMID: 39075850 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
